Viewing Study NCT04358393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-01-29 @ 6:27 AM
Study NCT ID: NCT04358393
Status: RECRUITING
Last Update Posted: 2024-02-01
First Post: 2020-04-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
Sponsor: Ascentage Pharma Group Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AML View
None Acute Myeloid Leukemia View
None Chronic Myelomonocytic Leukemia View
None CMML View
None Myelodysplastic Syndromes View
None High-risk Myelodysplastic Syndrome View
None MDS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TP53 View